NCT05066997Phase 2, phase 3Completed

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

Study sponsor: Oculis

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-04-10Actual
Enrollment · participants552Actual
Source updated2026-05-05Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Apr 2026

+ After

10 Apr 2026

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source